Medrad, Inc.: FDA filings under this applicant name
FDA lists 105 510(k) clearances under the applicant name “Medrad, Inc.” (first 1976, latest 2014), across 23 product codes in 5 review panels. Median 510(k) review time under this name: 75 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 2 | 116 |
| 2013 | 2 | 98 |
| 2014 | 1 | 335 |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| DXT | Injector And Syringe, Angiographic | 32 | 32 |
| MOS | Coil, Magnetic Resonance, Specialty | 18 | 18 |
| LNH | System, Nuclear Magnetic Resonance Imaging | 16 | 16 |
| FRN | Pump, Infusion | 6 | 6 |
| DQO | Catheter, Intravascular, Diagnostic | 3 | 3 |
| DQX | Wire, Guide, Catheter | 3 | 3 |
| LLZ | System, Image Processing, Radiological | 3 | 3 |
| MCW | Catheter, Peripheral, Atherectomy | 3 | 3 |
| QEZ | Aspiration Thrombectomy Catheter | 3 | 3 |
| DOY | Radioimmunoassay, Digoxin (3-H), Goat Antibody, 2nd Antibody Sep. | 2 | 2 |
Plus 13 more product codes.
Review panels
- Radiology (45)
- General Hospital (42)
- Cardiovascular (15)
- Clinical Toxicology (2)
- General and Plastic Surgery (1)
Most recent Medrad, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K133023 | JETSTREAM XC 2.4/3.4; JETSTREAM XC 2.1/3.0; JETSTREAM SC 1.85; JETSTREAM SC 1.6 | MCW | 2014-08-27 | 335 |
| K130381 | ANGIOJET ULTRA POWER PULSE KIT | QEW | 2013-07-29 | 165 |
| K130637 | JETSTREAM XC 2.4/3.4 SYSTEM; JETSTREAM XC 2.1/3.0 SYSTEM; JETSTREAM SC 1.85 SYSTEM; JETSTREAM SC 1.6 SYSTEM | MCW | 2013-04-10 | 30 |
| K122916 | JETSTREAM NAVITUS L SYSTEM JEYSTREAM NAVITUS SYSTEM JETSTREAM G3 SF SYSTEM JETSTREAM SF 1.6 SYSTEM | MCW | 2012-10-19 | 28 |
| K113363 | ANGIOJET SOLENT DISTA THROMBECTOMY SET | QEZ | 2012-06-06 | 204 |
| K113133 | MEDRAD MARK 7 ARTERION (PEDESTAL SYSTEM), (TABLE MOUNT SYSTEM), MEDRAD MARK 7 ARTERION ARTERION SYRINGE | DXT | 2011-12-15 | 52 |
| K113428 | ANGIOJET ULTRA DVX THROMBECTOMY SET | QEZ | 2011-12-02 | 11 |
| K112086 | MEDRAD MARK 7 ARTERION (PEDESTAL SYSTEM / TABLE MOUNT SYSTEM), MEDRAD MARK 7 ARTERION SYRINGE | DXT | 2011-10-14 | 85 |
| K111182 | ANGIOJET SOLENT OMNI THROMBECTOMY SET | QEZ | 2011-05-24 | 27 |
| K100798 | MEDRAD INTEGO PET INFUSION SYSTEM, SOURCE ADMINISTRATION SET, PATIENT ADMINSTRATIN SET MODEL INT SYS 100, INT CSS, INT C | FRN | 2010-06-23 | 93 |
95 earlier clearances. See the full list in Caduvo.
Recalls
29 product recalls in 17 recall events; 0 initiated in the last five years. Most recent: 2013-04-15.
13 product recalls in 11 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 2 initiated in the last five years. Most often: Bayer Medical Care, Inc. (5), Bayer Healthcare (3), Boston Scientific Corporation (3).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Medrad, Inc. (a text match, not an official crosswalk):
- A4220 — Refill kit for implantable infusion pump (via FRN)
- C8903 — Magnetic resonance imaging with contrast, breast; unilateral (via LNH)
- C8906 — Magnetic resonance imaging with contrast, breast; bilateral (via LNH)
- C8905 — Magnetic resonance imaging without contrast followed by with contrast, breast; unilateral (via LNH)
- C8908 — Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral (via LNH)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Medrad, Inc. / Bayer Medical Care, Inc. (2 510(k)s)
- Medrad Interventional/Possis (2 510(k)s)
- Medrad/Technology For People (1 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Medrad, Inc.?
FDA lists 105 510(k) clearances under the applicant name “Medrad, Inc.” (first 1976, latest 2014), across 23 product codes in 5 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Medrad, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Medrad, Inc. is 75 days.
Which FDA product codes appear under Medrad, Inc.?
The most frequent FDA product codes under this applicant name are DXT (Injector And Syringe, Angiographic, 32); MOS (Coil, Magnetic Resonance, Specialty, 18); LNH (System, Nuclear Magnetic Resonance Imaging, 16).
Next steps
- See all 105 Medrad, Inc. clearances with predicates and recalls
- Run predicate analysis for product code DXT, Medrad, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.